Global Active Pharmaceutical Ingredients (API) Market 2022-2032

Table of Content

1 Introduction 13
1.1 Industry Definition and Research Scope 13
1.1.1 Industry Definition 13
1.1.2 Research Scope 14
1.2 Research Methodology 17
1.2.1 Overview of Market Research Methodology 17
1.2.2 Market Assumption 18
1.2.3 Secondary Data 18
1.2.4 Primary Data 18
1.2.5 Data Filtration and Model Design 19
1.2.6 Market Size/Share Estimation 20
1.2.7 Research Limitations 21
1.3 Executive Summary 22

2 Market Overview and Dynamics 25
2.1 Market Size and Forecast 25
2.1.1 Impact of COVID-19 on World Economy 26
2.1.2 Impact of COVID-19 on the Market 29
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 36
2.2 Major Growth Drivers 40
2.3 Market Restraints and Challenges 48
2.4 Emerging Opportunities and Market Trends 51
2.5 Porter’s Fiver Forces Analysis 55

3 Segmentation of Global Market by Molecule 59
3.1 Market Overview by Molecule 59
3.2 Small Molecule APIs 61
3.3 Large Molecule APIs 62

4 Segmentation of Global Market by Synthesis 63
4.1 Market Overview by Synthesis 63
4.2 Synthetic API 65
4.2.1 Branded Synthetic API 66
4.2.2 Generic Synthetic API 67
4.3 Biotech API 68
4.3.1 Biotech API by Drug Type 69
4.3.1.1 Monoclonal Antibodies 70
4.3.1.2 Recombinant Proteins 71
4.3.1.3 Vaccines 72
4.3.1.4 Other Biotech APIs 73
4.3.2 Biotech API by Category 74
4.3.2.1 Innovative Biologic API 75
4.3.2.2 Generic Biosimilar API 76
4.3.3 Biotech API by Expression Technology 77
4.3.3.1 Mammalian Expression 78
4.3.3.2 Microbial Expression 79
4.3.3.3 Yeast Expression 80
4.3.3.4 Insect Expression 81
4.3.3.5 Other Expression Technologies 82
4.4 HPAPI 83
4.4.1 Branded HPAPI 84
4.4.2 Generic HPAPI 85

5 Segmentation of Global Market by Manufacturing Process 86
5.1 Market Overview by Manufacturing Process 86
5.2 Captive Manufacturing 88
5.2.1 Branded Captive API 89
5.2.2 Generic Captive API 90
5.3 Merchant Manufacturing 91
5.3.1 Merchant Manufacturing by Drug Type 92
5.3.1.1 Branded Merchant API 93
5.3.1.2 Generic Merchant API 94
5.3.2 Merchant Manufacturing by Drug Synthesis 95
5.3.2.1 Merchant Synthetic API 96
5.3.2.2 Merchant Biotech API 97

6 Segmentation of Global Market by Therapeutic Application 98
6.1 Market Overview by Therapeutic Application 98
6.2 Infectious Diseases 100
6.3 Oncology 101
6.4 Ophthalmology 102
6.5 Cardiovascular Disorders 103
6.6 Central Nervous System 104
6.7 Pulmonary Disorders 105
6.8 Orthopedics 106
6.9 Other Applications 107

7 Segmentation of Global Market by Drug Type 108
7.1 Market Overview by Drug Type 108
7.2 Branded Prescription Drugs 110
7.3 Generic Prescription Drugs 111
7.4 OTC Drugs 112

8 Segmentation of Global Market by Region 113
8.1 Geographic Market Overview 2022-2032 113
8.2 North America Market 2022-2032 by Country 117
8.2.1 Overview of North America Market 117
8.2.2 U.S. 120
8.2.3 Canada 130
8.2.4 Mexico 132
8.3 European Market 2022-2032 by Country 134
8.3.1 Overview of European Market 134
8.3.2 UK 137
8.3.3 France 139
8.3.4 Germany 141
8.3.5 Spain 143
8.3.6 Italy 145
8.3.7 Russia 147
8.3.8 Rest of European Market 149
8.4 Asia-Pacific Market 2022-2032 by Country 151
8.4.1 Overview of Asia-Pacific Market 151
8.4.2 China 154
8.4.3 Japan 156
8.4.4 India 159
8.4.5 Australia 161
8.4.6 South Korea 163
8.4.7 Rest of APAC Region 165
8.5 South America Market 2022-2032 by Country 167
8.5.1 Argentina 170
8.5.2 Brazil 172
8.5.3 Chile 174
8.5.4 Rest of South America Market 176
8.6 MEA Market 2022-2032 by Country 177
8.6.1 UAE 180
8.6.2 Saudi Arabia 182
8.6.3 South Africa 184
8.6.4 Other National Markets 186

9 Competitive Landscape 187
9.1 Overview of Key Vendors 187
9.2 New Product Launch, Partnership, Investment, and M&A 190
9.3 Company Profiles 191
AbbVie Inc. 191
Astrazeneca 193
Aurobindo Pharma Ltd. 198
BASF 201
Bayer AG 204
Boehringer Ingelheim 208
Catalent Inc. 213
Dr. Reddy’s Laboratories 216
F. Hoffmann-La Roche 218
GlaxoSmithKline plc 221
Lonza Group 226
Lupin Limited 230
Merck & Co., Inc. 233
Mylan NV 236
Novartis International AG 239
Pfizer Inc. 242
Sanofi 247
Sun Pharmaceutical Industries Ltd. 250
Teva Pharmaceutical Industries Ltd. 253
Thermo Fisher Scientific 255
Related Reports and Products 258

List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 17
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 20
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 22
Figure 4. Global Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 25
Figure 5. Impact of COVID-19 on Business 29
Figure 6. Primary Drivers and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market 40
Figure 7. GDP per capita in the World, 1960-2022, $ thousand 43
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million 44
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 45
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 45
Figure 11. Primary Restraints and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market 48
Figure 12. Investment Opportunity Analysis 52
Figure 13. Porter’s Fiver Forces Analysis of Global Active Pharmaceutical Ingredients (API) Market 55
Figure 14. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, % of Revenue 60
Figure 15. Global Addressable Market Cap in 2023-2032 by Molecule, Value ($ bn) and Share (%) 60
Figure 16. Global Active Pharmaceutical Ingredients (API) Market by Molecule: Small Molecule APIs, 2022-2032, $ bn 61
Figure 17. Global Active Pharmaceutical Ingredients (API) Market by Molecule: Large Molecule APIs, 2022-2032, $ bn 62
Figure 18. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, % of Revenue 63
Figure 19. Contribution to Global 2023-2032 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%) 64
Figure 20. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: Synthetic API, 2022-2032, $ bn 65
Figure 21. Global Active Pharmaceutical Ingredients (API) Market by Synthetic API: Branded Synthetic API, 2022-2032, $ bn 66
Figure 22. Global Active Pharmaceutical Ingredients (API) Market by Synthetic API: Generic Synthetic API, 2022-2032, $ bn 67
Figure 23. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: Biotech API, 2022-2032, $ bn 68
Figure 24. Global Biotech API Market by Drug Type: Monoclonal Antibodies, 2022-2032, $ bn 70
Figure 25. Global Biotech API Market by Drug Type: Recombinant Proteins, 2022-2032, $ bn 71
Figure 26. Global Biotech API Market by Drug Type: Vaccines, 2022-2032, $ bn 72
Figure 27. Global Biotech API Market by Drug Type: Other Biotech APIs, 2022-2032, $ bn 73
Figure 28. Global Biotech API Market by Category: Innovative Biologic API, 2022-2032, $ bn 75
Figure 29. Global Biotech API Market by Category: Generic Biosimilar API, 2022-2032, $ bn 76
Figure 30. Global Biotech API Market by Expression Technology: Mammalian Expression, 2022-2032, $ bn 78
Figure 31. Global Biotech API Market by Expression Technology: Microbial Expression, 2022-2032, $ bn 79
Figure 32. Global Biotech API Market by Expression Technology: Yeast Expression, 2022-2032, $ bn 80
Figure 33. Global Biotech API Market by Expression Technology: Insect Expression, 2022-2032, $ bn 81
Figure 34. Global Biotech API Market by Expression Technology: Other Expression Technologies, 2022-2032, $ bn 82
Figure 35. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: HPAPI, 2022-2032, $ bn 83
Figure 36. Global Active Pharmaceutical Ingredients (API) Market by HPAPI: Branded HPAPI, 2022-2032, $ bn 84
Figure 37. Global Active Pharmaceutical Ingredients (API) Market by HPAPI: Generic HPAPI, 2022-2032, $ bn 85
Figure 38. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, % of Revenue 86
Figure 39. Contribution to Global 2023-2032 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%) 87
Figure 40. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Captive Manufacturing, 2022-2032, $ bn 88
Figure 41. Global Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Branded Captive API, 2022-2032, $ bn 89
Figure 42. Global Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Generic Captive API, 2022-2032, $ bn 90
Figure 43. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Merchant Manufacturing, 2022-2032, $ bn 91
Figure 44. Global API Merchant Manufacturing Market by Drug Type: Branded Merchant API, 2022-2032, $ bn 93
Figure 45. Global API Merchant Manufacturing Market by Drug Type: Generic Merchant API, 2022-2032, $ bn 94
Figure 46. Global API Merchant Manufacturing Market by Drug Synthesis: Merchant Synthetic API, 2022-2032, $ bn 96
Figure 47. Global API Merchant Manufacturing Market by Drug Synthesis: Merchant Biotech API, 2022-2032, $ bn 97
Figure 48. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, % of Revenue 98
Figure 49. Contribution to Global 2023-2032 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%) 99
Figure 50. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Infectious Diseases, 2022-2032, $ bn 100
Figure 51. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Oncology, 2022-2032, $ bn 101
Figure 52. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Ophthalmology, 2022-2032, $ bn 102
Figure 53. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Cardiovascular Disorders, 2022-2032, $ bn 103
Figure 54. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Central Nervous System, 2022-2032, $ bn 104
Figure 55. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Pulmonary Disorders, 2022-2032, $ bn 105
Figure 56. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Orthopedics, 2022-2032, $ bn 106
Figure 57. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Other Applications, 2022-2032, $ bn 107
Figure 58. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, % of Revenue 108
Figure 59. Contribution to Global 2023-2032 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%) 109
Figure 60. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: Branded Prescription Drugs, 2022-2032, $ bn 110
Figure 61. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: Generic Prescription Drugs, 2022-2032, $ bn 111
Figure 62. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: OTC Drugs, 2022-2032, $ bn 112
Figure 63. Global Market Snapshot by Region 113
Figure 64. Geographic Spread of Worldwide Active Pharmaceutical Ingredients (API) Market, 2022-2032, % of Revenue 114
Figure 65. Contribution to Global 2023-2032 Cumulative Revenue by Region, Value ($ bn) and Share (%) 115
Figure 66. North American Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 118
Figure 67. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 118
Figure 68. Contribution to North America 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 119
Figure 69. U.S. Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 121
Figure 70. Manufacturing Sites of APIs for U.S. Market by Country or Region, 126
Figure 71. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List 126
Figure 72. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List 127
Figure 73. Canada Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 130
Figure 74. Active Pharmaceutical Ingredients (API) Market in Mexico, 2022-2032, $ bn 132
Figure 75. European Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 135
Figure 76. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 135
Figure 77. Contribution to Europe 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 136
Figure 78. Active Pharmaceutical Ingredients (API) Market in UK, 2022-2032, $ bn 137
Figure 79. Active Pharmaceutical Ingredients (API) Market in France, 2022-2032, $ bn 139
Figure 80. Active Pharmaceutical Ingredients (API) Market in Germany, 2022-2032, $ bn 141
Figure 81. Active Pharmaceutical Ingredients (API) Market in Spain, 2022-2032, $ bn 143
Figure 82. Active Pharmaceutical Ingredients (API) Market in Italy, 2022-2032, $ bn 145
Figure 83. Active Pharmaceutical Ingredients (API) Market in Russia, 2022-2032, $ bn 147
Figure 84. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2022-2032, $ bn 149
Figure 85. Asia-Pacific Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 152
Figure 86. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 152
Figure 87. Contribution to APAC 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 153
Figure 88. Active Pharmaceutical Ingredients (API) Market in China, 2022-2032, $ bn 154
Figure 89. Active Pharmaceutical Ingredients (API) Market in Japan, 2022-2032, $ bn 157
Figure 90. Active Pharmaceutical Ingredients (API) Market in India, 2022-2032, $ bn 159
Figure 91. Active Pharmaceutical Ingredients (API) Market in Australia, 2022-2032, $ bn 161
Figure 92. Active Pharmaceutical Ingredients (API) Market in South Korea, 2022-2032, $ bn 163
Figure 93. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2022-2032, $ bn 165
Figure 94. South America Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 168
Figure 95. Breakdown of South America Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 168
Figure 96. Contribution to South America 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 169
Figure 97. Active Pharmaceutical Ingredients (API) Market in Argentina, 2022-2032, $ bn 170
Figure 98. Active Pharmaceutical Ingredients (API) Market in Brazil, 2022-2032, $ bn 172
Figure 99. Active Pharmaceutical Ingredients (API) Market in Chile, 2022-2032, $ bn 174
Figure 100. Active Pharmaceutical Ingredients (API) Market in Rest of South America, 2022-2032, $ bn 176
Figure 101. Active Pharmaceutical Ingredients (API) Market in MEA, 2022-2032, $ bn 178
Figure 102. Breakdown of MEA Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 178
Figure 103. Contribution to MEA 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 179
Figure 104. Active Pharmaceutical Ingredients (API) Market in UAE, 2022-2032, $ bn 180
Figure 105. Active Pharmaceutical Ingredients (API) Market in Saudi Arabia, 2022-2032, $ bn 182
Figure 106. Active Pharmaceutical Ingredients (API) Market in South Africa, 2022-2032, $ bn 184
Figure 107. Growth Stage of Global Active Pharmaceutical Ingredients (API) Industry over the Forecast Period 187
Figure 108. AstraZeneca: Breakdown of Revenue by Therapy Area, 2022 194
Figure 109. AstraZeneca: Breakdown of Revenue by Region, 2022 194
Figure 110. Boehringer Ingelheim: Revenue by Business Segment, 2019-2022 209
Figure 111. Boehringer Ingelheim: R&D Investement, 2019-2022 210

List of Tables

List of Tables:

Table 1. Snapshot of Global Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2022-2032 23
Table 2. World Economic Outlook, 2021-2031 27
Table 3. World Economic Outlook, 2021-2023 28
Table 4. Scenarios for Economic Impact of Ukraine Crisis 37
Table 5. World Health Spending by Region, $ bn, 2013-2020 46
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 47
Table 7. Main Product Trends and Market Opportunities in Global Active Pharmaceutical Ingredients (API) Market 51
Table 8. Global Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, $ bn 59
Table 9. Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 63
Table 10. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2022-2032, $ bn 65
Table 11. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2022-2032, $ bn 69
Table 12. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2022-2032, $ bn 74
Table 13. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2022-2032, $ bn 77
Table 14. Global Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2022-2032, $ bn 83
Table 15. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 86
Table 16. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2022-2032, $ bn 88
Table 17. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2022-2032, $ bn 92
Table 18. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2022-2032, $ bn 95
Table 19. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 98
Table 20. Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, $ bn 108
Table 21. Global Active Pharmaceutical Ingredients (API) Market by Region, 2022-2032, $ bn 114
Table 22. Leading National Active Pharmaceutical Ingredients (API) Market, 2022 and 2032, $ bn 116
Table 23. North America Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 119
Table 24. U.S. Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 122
Table 25. U.S. Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 122
Table 26. U.S. Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 122
Table 27. Top 15 Countries Supplying API for Medicines Consumed in the US, 2019, % based on Dollar Value 124
Table 28. Canada Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 131
Table 29. Canada Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 131
Table 30. Canada Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 131
Table 31. Mexico Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 133
Table 32. Mexico Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 133
Table 33. Mexico Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 133
Table 34. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 136
Table 35. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 138
Table 36. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 138
Table 37. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 138
Table 38. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 140
Table 39. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 140
Table 40. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 140
Table 41. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 142
Table 42. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 142
Table 43. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 142
Table 44. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 144
Table 45. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 144
Table 46. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 144
Table 47. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 146
Table 48. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 146
Table 49. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 146
Table 50. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 148
Table 51. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 148
Table 52. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 148
Table 53. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2022-2032, $ bn 150
Table 54. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 153
Table 55. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 155
Table 56. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 155
Table 57. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 155
Table 58. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 158
Table 59. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 158
Table 60. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 158
Table 61. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 160
Table 62. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 160
Table 63. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 160
Table 64. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 162
Table 65. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 162
Table 66. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 162
Table 67. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 164
Table 68. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 164
Table 69. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 164
Table 70. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2022-2032, $ bn 166
Table 71. South America Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 169
Table 72. Argentina Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 171
Table 73. Argentina Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 171
Table 74. Argentina Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 171
Table 75. Brazil Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 173
Table 76. Brazil Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 173
Table 77. Brazil Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 173
Table 78. Chile Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 175
Table 79. Chile Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 175
Table 80. Chile Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 175
Table 81. MEA Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 179
Table 82. UAE Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 181
Table 83. UAE Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 181
Table 84. UAE Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 181
Table 85. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 183
Table 86. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 183
Table 87. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 183
Table 88. South Africa Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 185
Table 89. South Africa Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 185
Table 90. South Africa Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 185
Table 91. AbbVie Inc.: Company Snapshot 191
Table 92. AbbVie Inc.: Business Segmentation 192
Table 93. AbbVie Inc.: Product Portfolio 192
Table 94. Astrazeneca: Company Snapshot 193
Table 95. Aurobindo Pharma Ltd.: Company Snapshot 198
Table 96. Aurobindo Pharma Ltd.: Product Portfolio 199
Table 97. BASF: Company Snapshot 201
Table 98. BASF: Business Segmentation 202
Table 99. Bayer AG: Company Snapshot 204
Table 100. Bayer AG: Business Segmentation 205
Table 101. Bayer AG: Product Portfolio 205
Table 102. Boehringer Ingelheim: Company Snapshot 208
Table 103. Boehringer Ingelheim: Product Portfolio 209
Table 104. Catalent Inc.: Company Snapshot 213
Table 105. Catalent Inc.: Business Segmentation 214
Table 106. Catalent Inc.: Product Portfolio 214
Table 107. Dr. Reddy’s Laboratories: Company Snapshot 216
Table 108. Dr. Reddy’s Laboratories: Business Segmentation 216
Table 109. F. Hoffmann-La Roche: Company Snapshot 218
Table 110. F. Hoffmann-La Roche: Clinical Trial Service 218
Table 111. F. Hoffmann-La Roche: Business Segmentation 219
Table 112. F. Hoffmann-La Roche: Revenue by Region 219
Table 113. GlaxoSmithKline: Company Snapshot 221
Table 114. GlaxoSmithKline: Business Segmentation 222
Table 115. GlaxoSmithKline: Product Portfolio 223
Table 116. Lonza Group: Company Snapshot 226
Table 117. Lonza Group: Business Segmentation 227
Table 118. Lonza Group: Product Portfolio 227
Table 119. Lupin Limited: Company Snapshot 230
Table 120. Lupin Limited: Business Segmentation 231
Table 121. Merck & Co., Inc.: Company Snapshot 233
Table 122. Merck & Co., Inc.: Business Segmentation 234
Table 123. Mylan NV: Company Snapshot 236
Table 124. Mylan NV: Breakdown of Revenue by Region, 2022 237
Table 125. Mylan NV: Breakdown of Revenue by Product Category, 2022 237
Table 126. Novartis International AG: Company Snapshot 239
Table 127. Novartis International AG: Business Segmentation 240
Table 128. Pfizer Inc.: Company Snapshot 242
Table 129. Pfizer Inc.: Business Segmentation 243
Table 130. Pfizer Inc.: Breakdown of Revenue by Product Category 243
Table 131. Pfizer Inc.: Breakdown of Revenue by Region 244
Table 132. Pfizer Inc.: Product Portfolio 244
Table 133. Sanofi: Company Snapshot 247
Table 134. Sanofi: Business Segmentation 248
Table 135. Sanofi: Breakdown of Revenue by Region 248
Table 136. Sun Pharmaceutical Industries Limited: Company Snapshot 250
Table 137. Teva Pharmaceutical Industries Ltd.: Company Snapshot 253
Table 138. Teva Pharmaceutical Industries Ltd.: Business Segmentation 254
Table 139. Thermo Fisher Scientific: Company Snapshot 255
Table 140. Thermo Fisher Scientific: Breakdown of Revenue by Business Segment, 2020, % 256
Table 141. Thermo Fisher Scientific: Breakdown of Revenue by Region, 2020, % 256